ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: GM Prizes To Withers, Cory, Korsmeyer, Horvitz; Univ. of Chicago, City of Hope Are Comprehensive

May 1, 1998

Seffrin; First Year ACS Shows “Simple Problems Aren’t”

August 6, 1993

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

In Brief: Interim Dean Henney Looking for Cancer Center Director; Shingleton Gets James Ewing Award

June 10, 1988

Obey Erred On Criticism Of Pap Test Cost, FCRC Construction

August 10, 1979

NCI-Approved Clinical Trials

November 24, 2006